banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
3- (S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl) pyrroloidine-L-(+)-tartarate CAS 134002-26-9

3- (S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl) pyrroloidine-L-(+)-tartarate CAS 134002-26-9

CAS TSIS TAU: 134002-26-9
Cov mis mos molecular: C22H26N2O7
Molecular phaus: 430.45100
EINECS TSIS YOG: 603-789-5
MDL NO: NA

Txhawb tshuaj

Khoom Piav Qhia:

Khoom Npe: 3- (S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl) pyrroloidine-L-(+)-tartarate CAS TSIS: 134002-26-9

Lub ntsiab lus:

(2R, 3R) -2,3-dihydroxybutanedioic acid, 2,2-diphenyl-2-[(3S) -pyrrolidin-3-yl] acetamide;

(S) -2,2-Diphenyl-2- (pyrrolidin-3-yl) acetamide (2R, 3R) -2,3-dihydroxysuccinate ;

Darifenacin Nruab Nrab 8;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb hmoov

Kev Ntsuas: ≥99.00%

Qhov tseeb pawg: 430.174011

(S) -α, α-Diphenyl-3-pyrrolidineacetamide yog qhov tsis huv tshwm sim hauv kev sib xyaw ntawm Darifenacin.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.


Cim npe nrov: 3- (s)-(+)-(1-carbamoyl-1,1-diphenylmethyl) pyrroloidine-l-(+)-tartarate cas 134002-26-9, tuam ntxhab, cov chaw muag khoom, lub Hoobkas , yuav, hauv Tshuag

Xa kev nug